Use of the Depression, Anxiety and Stress Scale (DASS-21) Questionnaire to Assess Levels of Depression, Anxiety, and Stress in Healthcare and Administrative Staff in 5 Oncology Institutions in Bosnia and Herzegovina During the 2020 COVID-19 Pandemic

Inga Marijanović; Marija Kraljević; Teo Buhovac; Timur Cerić; Alma Mekić Abazović; Jasmina Alidžanović; Zdenka Gojković; Emir Sokolović

doi:10.12659/MSM.930812

19 April 2021 : Clinical Research

Use of the Depression, Anxiety and Stress Scale (DASS-21) Questionnaire to Assess Levels of Depression, Anxiety, and Stress in Healthcare and Administrative Staff in 5 Oncology Institutions in Bosnia and Herzegovina During the 2020 COVID-19 Pandemic

Inga Marijanović^1ABDEF, Marija Kraljević^1ABDEF*, Teo Buhovac^1ABDEF, Timur Cerić^2BD, Alma Mekić Abazović^3BD, Jasmina Alidžanović^4BD, Zdenka Gojković^5BD, Emir Sokolović^6CD

DOI: 10.12659/MSM.930812

Med Sci Monit 2021; 27:e930812

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 2 Overall prevalence of depression, anxiety, and stress among oncology staff in Bosnia and Herzegovina during the coronavirus disease 2019 pandemic.

Variables	Frequency (n)	Percent (%)

Normal	131	74.9
Mild	22	12.6
Moderate	13	7.4
Severe	6	3.4
Extremely severe	3	1.7

Normal	124	70.9
Mild	18	10.3
Moderate	20	11.4
Severe	5	2.9
Extremely severe	8	4.6

Normal	125	71.4
Mild	23	13.1
Moderate	17	9.7
Severe	6	3.4
Extremely severe	4	2.3

Back to the Article

Use of the Depression, Anxiety and Stress Scale (DASS-21) Questionnaire to Assess Levels of Depression, Anxiety, and Stress in Healthcare and Administrative Staff in 5 Oncology Institutions in Bosnia and Herzegovina During the 2020 COVID-19 Pandemic

Your Privacy